Global Continuous Manufacturing Market Size (2024 - 2029)

Continuous Manufacturing Market Analysis

The continuous manufacturing market is projected to register a CAGR of 12.8% during the forecast period (2022 - 2027).

The sudden onset of Covid-19 resulted in high demand for pharmaceuticals. The imposition of strict lockdowns across the globe resulted in the lack of labor and supply thereby resulting in the huge demand for pharmaceuticals. Hence, the COVID-19 pandemic led to increasing demand for continuous manufacturing, thereby contributing to the growth of the market. For instance, the article titled "The pandemic effect: making continuous manufacturing a reality" published in September 2021 mentioned that with the ongoing COVID-19 pandemic and the increasing demand for low-cost vaccines and other pandemic-related treatments at an all-time high, big pharmaceutical companies are stepping up efforts to make continuous manufacturing a reality. Thus, the outbreak of the COVID-19 pandemic had a significant impact on the growth of the market.

Continuous manufacturing has been gaining traction in the market studied due to its potential to improve the quality and consistency of medication at lower costs. Furthermore, the adaptation of continuous manufacturing in the pharma industry and the rising demand for medication due to the growing prevalence of diseases around the world is likely to propel the market growth. Continuous manufacturing help manufacturers meet the market demand at the same time, which lowers the cost of manufacturing.

Moreover, technological advancements in manufacturing and support from government agencies are expected to bolster the studied market's growth. The increasing approval for continuous manufacturing is also expected to boost the growth of the market. For instance, in October 2021, the United States Food and Drug Administration (FDA) approved four drugs using continuous manufacturing, which included the first regulatory application using continuous manufacturing for an active pharmaceutical ingredient.

Additionally, the increasing collaborations by the market players are expected to drive the growth of the market. For instance, in September 2020, Emerson and Integra CMS collaborated to accelerate the adoption of continuous pharmaceutical manufacturing.

Thus the above-mentioned factors are expected to drive the growth of the studied market during the forecast period. However, the slow adaptation of continuous manufacturing, lack of regulatory, and technical clarity regarding guidelines may impede the market growth of the market over the forecast period.

Continuous Manufacturing Industry Segmentation

As per the scope of the report, continuous manufacturing refers to the manufacturing process of products without any interruption. It is the opposite of batch manufacturing. Continuous manufacturing is a method for manufacturing pharmaceutical products from end to end on a single, uninterrupted production line. The continuous manufacturing market is segmented by Product (Integrated Continuous Manufacturing and Semi Continuous Manufacturing), Application(API manufacturing, and End Product Manufacturing), End User (Contract Manufacturers, Pharmaceutical Companies and Other End Users), and Geography (North America, Europe, Asia-pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values (in USD million) for the above segments.